BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND EML4, ENSG00000143924, 27436 AND Treatment
14 results:

  • 1. Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases.
    Demleitner M; Erlenbach-Wünsch K; Coras R; Erber R; Polifka I; Eyüpoğlu I; Fuchs F; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2023 Apr; 63():152082. PubMed ID: 36634550
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Ceritinib in the treatment of an adult patient with advanced neuroblastoma positive to the somatic activating mutation of ALK F1174L.].
    Soto Parra HJ; Noto L; Aiello MM
    Recenti Prog Med; 2020 Dec; 111(12):58e-62e. PubMed ID: 33362184
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.
    Leal JL; Peters G; Szaumkessel M; Leong T; Asadi K; Rivalland G; Do H; Senko C; Mitchell PL; Quing CZ; Dobrovic A; Thapa B; John T
    Lung Cancer; 2020 Aug; 146():154-159. PubMed ID: 32540558
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A case of primary pulmonary atypical carcinoid with eml4-ALK rearrangement.
    Liu N; Wang J; Fu X; Zheng X; Gao H; Tian T; Ruan Z; Yao Y
    Cancer Biol Ther; 2020; 21(1):12-16. PubMed ID: 31559892
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Diagnosis of lung biopsy employing the 2015 WHO criteria and detection of related oncogenic driver mutations].
    Fang F; Qiao XB; Yang L; Di J; Hu ST; Liu DG; Lyu N
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):270-275. PubMed ID: 30955261
    [No Abstract]    [Full Text] [Related]  

  • 6. Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations.
    Wang AC; Jones DTW; Abecassis IJ; Cole BL; Leary SES; Lockwood CM; Chavez L; Capper D; Korshunov A; Fallah A; Wang S; Ene C; Olson JM; Geyer JR; Holland EC; Lee A; Ellenbogen RG; Ojemann JG
    Mol Cancer Res; 2018 Oct; 16(10):1491-1498. PubMed ID: 30006355
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ALK Inhibitor Response in Melanomas Expressing
    Couts KL; Bemis J; Turner JA; Bagby SM; Murphy D; Christiansen J; Hintzsche JD; Le A; Pitts TM; Wells K; Applegate A; Amato C; Multani P; Chow-Maneval E; Tentler JJ; Shellman YG; Rioth MJ; Tan AC; Gonzalez R; Medina T; Doebele RC; Robinson WA
    Mol Cancer Ther; 2018 Jan; 17(1):222-231. PubMed ID: 29054983
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of the ALK receptor in cancer biology.
    Hallberg B; Palmer RH
    Ann Oncol; 2016 Sep; 27 Suppl 3():iii4-iii15. PubMed ID: 27573755
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
    Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
    J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel lead compound CM-118: antitumor activity and new insight into the molecular mechanism and combination therapy strategy in c-Met- and ALK-dependent cancers.
    Meng L; Shu M; Chen Y; Yang D; He Q; Zhao H; Feng Z; Liang C; Yu K
    Cancer Biol Ther; 2014 Jun; 15(6):721-34. PubMed ID: 24618813
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
    Karkouche R; Bachet JB; Sandrini J; Mitry E; Penna C; Côté JF; Blons H; Penault-Llorca F; Rougier P; Saint André JP; Emile JF
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1430-7. PubMed ID: 23114745
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The R1275Q neuroblastoma mutant and certain ATP-competitive inhibitors stabilize alternative activation loop conformations of anaplastic lymphoma kinase.
    Epstein LF; Chen H; Emkey R; Whittington DA
    J Biol Chem; 2012 Oct; 287(44):37447-57. PubMed ID: 22932897
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
    Kelleher FC; McDermott R
    Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.